cysteamine bitartrate
Orphan Drug Cold Chain RequiredFDA Approved
Description
Cysteamine bitartrate is an aminothiol compound that acts as a cystine-depleting agent. It is used in the treatment of corneal cystine crystal accumulation and has applications in metabolic disorders. The ophthalmic formulation helps dissolve corneal crystals in various genetic conditions.
Indications & Therapeutic Use
corneal cystine crystal deposits, metabolic disorders with ocular manifestations
Linked Diseases:
Global Availability (5 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
cysteamine bitartrate
| Generic Name | cysteamine bitartrate |
| Brands | 1 brand available |
| Active Ingredient | cysteamine bitartrate |
| Drug Class | corneal cystine crystal deposits |
| Manufacturer | Recordati Rare Diseases |
| Dosage Forms | Ophthalmic solution, 0.44% |
| Medical Code | S01XA |
| Orphan Status | Yes — Orphan Drug |
| Cold Chain | Required |
| Lead Time | 14 days |
| Reg. Status | FDA Approved |
| Clinical Trial | NCT00894309 |
| Countries | 5 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations6 Validated Nodes